These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 30113768)

  • 1. Prognostic evaluation of perinephric fat, renal sinus fat, and renal vein invasion for patients with pathological stage T3a clear-cell renal cell carcinoma.
    Shah PH; Lyon TD; Lohse CM; Cheville JC; Leibovich BC; Boorjian SA; Thompson RH
    BJU Int; 2019 Feb; 123(2):270-276. PubMed ID: 30113768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma.
    Margulis V; Tamboli P; Matin SF; Meisner M; Swanson DA; Wood CG
    J Urol; 2007 Nov; 178(5):1878-82. PubMed ID: 17868733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor size and Fuhrman grade further enhance the prognostic impact of perinephric fat invasion and renal vein extension in T3a staging of renal cell carcinoma.
    Chen K; Lee BL; Huang HH; Tan BY; Lee LS; Ng LG; Lau W; Yuen JS
    Int J Urol; 2017 Jan; 24(1):51-58. PubMed ID: 27757999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical impact of segmental renal vein invasion on recurrence in patients with clinical T1 renal cell carcinoma undergoing partial nephrectomy.
    Yoshida T; Ohe C; Tsuzuki T; Sugi M; Kinoshita H; Tsuta K; Matsuda T
    Int J Clin Oncol; 2020 Mar; 25(3):464-471. PubMed ID: 31531786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
    Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
    Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined renal sinus fat and perinephric fat renal cell carcinoma invasion has a worse prognosis than either alone.
    Kresowik TP; Johnson MT; Joudi FN
    J Urol; 2010 Jul; 184(1):48-52. PubMed ID: 20478592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage T3a renal cell carcinoma: staging accuracy of CT for sinus fat, perinephric fat or renal vein invasion.
    Sokhi HK; Mok WY; Patel U
    Br J Radiol; 2015 Jan; 88(1045):20140504. PubMed ID: 25410425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of prognosis between patients undergoing radical nephrectomy versus partial nephrectomy for renal cell carcinoma ≤7 cm T3aN0/xM0: Survival benefit is biased toward partial nephrectomy.
    Liu S; Feng C; Liu C; Wang Z
    Cancer Med; 2021 Dec; 10(24):8909-8923. PubMed ID: 34779154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differing risk of cancer death among patients with pathologic T3a renal cell carcinoma: identification of risk categories according to fat infiltration and renal vein thrombosis.
    Baccos A; Brunocilla E; Schiavina R; Borghesi M; Rocca GC; Chessa F; Saraceni G; Fiorentino M; Martorana G
    Clin Genitourin Cancer; 2013 Dec; 11(4):451-7. PubMed ID: 23816525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors for renal cell carcinoma with tumor thrombus extension.
    Klatte T; Pantuck AJ; Riggs SB; Kleid MD; Shuch B; Zomorodian N; Kabbinavar FF; Belldegrun AS
    J Urol; 2007 Oct; 178(4 Pt 1):1189-95; discussion 1195. PubMed ID: 17698087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perinephric and Sinus Fat Invasion in Stage pT3a Tumors Managed by Partial Nephrectomy.
    Mouracade P; Dagenais J; Chavali JS; Kara O; Nelson RJ; Maurice MJ; Reese J; Rini BI; Kaouk JH
    Clin Genitourin Cancer; 2018 Oct; 16(5):e1077-e1082. PubMed ID: 28818550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic implications of renal vein involvement in T3a renal cancer.
    Clark KF; Risendal M; Hill S; Deem S
    Can J Urol; 2019 Apr; 26(2):9715-9719. PubMed ID: 31012835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Prognostic Value of Extrarenal Involvement in Patients With Non-Metastatic Renal Cell Cancer.
    Musso G; Fallara G; Rosiello G; Martini A; Re C; Cei F; Basile G; Cignoli D; Colandrea G; Rowe I; Larcher A; Salonia A; Montorsi F; Capitanio U
    Clin Genitourin Cancer; 2023 Aug; 21(4):e279-e285.e1. PubMed ID: 36944568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Microscopic Wall Invasion of the Renal Vein or Inferior Vena Cava on Cancer-specific Survival in Patients with Renal Cell Carcinoma and Tumor Thrombus: A Multi-institutional Analysis from the International Renal Cell Carcinoma-Venous Thrombus Consortium.
    Rodriguez Faba O; Linares E; Tilki D; Capitanio U; Evans CP; Montorsi F; Martínez-Salamanca JI; Libertino J; Gontero P; Palou J
    Eur Urol Focus; 2018 Apr; 4(3):435-441. PubMed ID: 28753848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does stage T3a renal cell carcinoma embrace a homogeneous group of patients?
    Gofrit ON; Shapiro A; Pizov G; Landau EH; Katz R; Zorn KC; Pode D
    J Urol; 2007 May; 177(5):1682-6. PubMed ID: 17437782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the prognostic significance of perirenal fat invasion and tumor size in patients with pT1-pT3a localized renal cell carcinoma in a comprehensive multicenter study of the CORONA project. Can we improve prognostic discrimination for patients with stage pT3a tumors?
    Brookman-May SD; May M; Wolff I; Zigeuner R; Hutterer GC; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Tubaro A; Coman I; Truss M; Dalpiaz O; Feciche B; Figenshau RS; Madison K; Sánchez-Chapado M; Santiago Martin Mdel C; Salzano L; Lotrecchiano G; Zastrow S; Wirth M; Sountoulides P; Shariat S; Waidelich R; Stief C; Gunia S; ;
    Eur Urol; 2015 May; 67(5):943-51. PubMed ID: 25684695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of venous tumour thrombus consistency (solid vs friable) on cancer-specific survival in patients with renal cell carcinoma.
    Bertini R; Roscigno M; Freschi M; Strada E; Angiolilli D; Petralia G; Matloob R; Sozzi F; Capitanio U; Da Pozzo LF; Colombo R; Guazzoni G; Cremonini A; Montorsi F; Rigatti P
    Eur Urol; 2011 Aug; 60(2):358-65. PubMed ID: 21640483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prognostic Impact of a Positive Vascular Margin on pT3 Clear Cell Renal Cell Carcinoma.
    Liu NW; Wren JD; Vertosick E; Lee JK; Power NE; Benfante NE; Kimm SY; Bains MS; Sjoberg DD; Russo P; Coleman JA
    J Urol; 2016 Feb; 195(2):264-9. PubMed ID: 26363467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reappraisal of T3N0/NxM0 renal cell carcinoma: significance of extent of fat invasion, renal vein invasion, and adrenal invasion.
    Jung SJ; Ro JY; Truong LD; Ayala AG; Shen SS
    Hum Pathol; 2008 Nov; 39(11):1689-94. PubMed ID: 18656240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Risk factors for recurrence in pT3aN0M0 renal cell carcinoma according to 2009 TNM classification].
    Utsunomiya N; Kono Y; Matsumoto K; Sumiyoshi T; Masuda N; Shiraishi Y; Negoro H; Tsunemori H; Sugino Y; Okubo K; Okada T; Segawa T; Muguruma K; Kawakita M
    Hinyokika Kiyo; 2014 Jan; 60(1):1-5. PubMed ID: 24594765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.